A large study looked at over 2,400 people in the UK Biobank who had aortic regurgitation. Researchers measured levels of a protein called UMOD in their blood. They compared these levels to standard kidney markers like creatinine. The main goal was to see if UMOD could predict when someone might need heart valve surgery.
The results showed that higher UMOD levels were connected to a lower risk of needing aortic valve replacement. Specifically, the chance of surgery was about 43% lower for those with higher levels. This link stayed strong even after accounting for other health factors. The study also found that higher UMOD levels were tied to less stiff arteries.
This information is important because most past research focused on patients who already had severe disease. This new work looks at the disease earlier, before surgery is needed. While this is an observational study and not a trial, it offers a new way to track how the condition changes over time. More research is needed to confirm these findings in other groups.
Doctors can use these results to better understand how aortic regurgitation develops. Knowing about UMOD might help identify patients who are less likely to need surgery soon. This could lead to better care plans for people with this heart condition.